BPEA Acquires Healthcare Tech Firm CitiusTech for Over $1 Billion, Outbidding KKR and Goldman Sachs

Recently, VCBeat (WeChat ID: vcbeat) learned from foreign media that Asian private equity firm Baring Private Equity Asia (BPEA) plans to acquire healthcare analytics company CitiusTech for over $1 billion, with the formal agreement to be signed shortly.

It is reported that the acquisition bidding process was highly competitive, with BPEA defeating major private equity firms such as KKR India Financial Services (KKR), Goldman Sachs, and Chrys Capital to ultimately complete the acquisition of CitiusTech.

CitiusTech, established in 2005 and headquartered in New Jersey, USA, is a healthcare technology services company. The company specializes in providing healthcare technology support to healthcare and life sciences organizations, serves as a strategic partner to many major healthcare companies, and wields significant global influence. CitiusTech employs over 3,000 people and maintains offices in India, Singapore, the United Arab Emirates, the United Kingdom, and the United States.

CitiusTech is at the forefront of digital transformation, with business operations spanning multiple domains of digital technology, such as business intelligence, the Internet of Things (IoT), big data, cloud computing, predictive analytics, and data science. The company’s specialized healthcare technology team is dedicated to developing end-to-end applications and building healthcare technology platforms—including Integrated Cloud Suite, Medictiv, and H-Scale—to strengthen medical data management and enhance the operational efficiency of healthcare institutions. CitiusTech plays a significant role in driving technological transformation and creating new models for healthcare technology services. Leveraging cutting-edge technology, superior service quality, and deep expertise in healthcare technology, the company has established long-term partnerships with dozens of leading healthcare technology companies worldwide.

CitiusTech collaborates with healthcare companies, pharmaceutical firms, and contract research organizations (CROs) to rapidly integrate and store medical data using its proprietary Integrated AnalytiX platform. This platform not only facilitates drug safety validation, non-destructive testing, and equipment data analysis but also provides big data-driven mobile health reports and healthcare industry analysis reports for various sectors. Through such analysis, CitiusTech proposes solutions to address enterprise-specific challenges, helping clients optimize their products to navigate complex industry dynamics.

In the life sciences sector, CitiusTech has partnered with FluidEdge Consulting, a healthcare technology operations company, to provide pharmaceutical, biotechnology, and medical device companies with innovative technology and operational services, including digital health technologies, clinical trial optimization services, and patient survey services.

BPEA, established in 1997 and headquartered in Hong Kong, China, is the largest private equity firm in the Asia-Pacific region. The company focuses on growth equity investments and mid-market acquisitions, with primary investment markets including China, India, Japan, Singapore, Hong Kong, and Taiwan. BPEA drives the development of its portfolio companies through specialized operational expertise and regards social responsibility as a primary consideration in its investment decisions.

BPEA boasts a professional investment and operations team, having previously acquired multiple venture capital firms, educational institutions, and pharmaceutical companies. Its investment committee members have an average of over 18 years of work experience in Asia. This acquisition marks BPEA’s first foray into medical technology investment in India, following its prior acquisitions of healthcare platforms and pharmaceutical companies in China and Japan.

(Compiled by Xu Xiaoxue)